Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim in Pediatric CIT
NCT06201663Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Dec 2023
- Primary completion
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of romiplostim in chemotherapy-induced thrombocytopenia (CIT), sponsored by Ain Shams University. Started Dec 2023; status: recruiting.
02
Drugs
romiplostim
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NCT06201663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06201663.